Background/objectives: The aim was to evaluate the incidence of late AMD in eyes with intermediate AMD (iAMD) over two years. Subjects/methods: In this multicentre cohort study, participants with iAMD were classified as: (i) iAMD without incomplete retinal pigment epithelium or outer retinal atrophy (iRORA) or subretinal drusenoid deposits (SDD); (ii) iAMD with SDD with no iRORA; (iii) iAMD with iRORA with no SDD and (iv) iAMD with iRORA and SDD. Factors associated with the incidence of late AMD were analysed using an interval-censored Weibull parametric proportional hazards model. Results: 983 eyes from 805 participants were analysed. Model-based cumulative incidence at nominal 2 years was 13.1% (95% CI 10.8–15.6%) for late AMD, 7.6% (95% CI 5.9–9.3%) for nAMD as the cause and 5.5% (95% CI 4.1–7.3%) for cRORA as the cause. Participants aged 75–84 (adjusted HR [aHR] 1.66, 95% CI 1.13–2.46; P = 0.01), 85 years+ (aHR 2.48, 95% CI 1.49–4.15; P = 0.001), presence of iRORA (aHR 1.50, 95% CI 1.05–2.16; P = 0.03), fellow-eye nAMD (aHR 3.23, 95% CI 2.04–5.12; P < 0.001) and BRVA 70–79 (vs 80 or better ETDRS letters: aHR 1.65, 95% CI 1.09–2.49; P = 0.02) had increased hazard of late AMD. Eyes that transitioned to neovascular AMD (nAMD) by 2 years (within tolerance window) displayed the greatest loss in BRVA compared to other phenotypes (–6.01 letters, SD 11.35). Conclusions: Approximately 13% of eyes with iAMD progressed to late AMD within 2 years. Eyes that transitioned to nAMD experienced the greatest loss in BRVA.
Transition from intermediate to late AMD and associated changes in vision by two years in a multicentre cohort study in Europe- INTERCEPT-AMD Report 3 / S. Gurudas, I.M.. - In: EYE. - ISSN 1476-5454. - 40:(2026 Nov), pp. 2532-2540. [10.1038/s41433-026-04759-9]
Transition from intermediate to late AMD and associated changes in vision by two years in a multicentre cohort study in Europe- INTERCEPT-AMD Report 3
S. VujosevicPenultimo
;
2026
Abstract
Background/objectives: The aim was to evaluate the incidence of late AMD in eyes with intermediate AMD (iAMD) over two years. Subjects/methods: In this multicentre cohort study, participants with iAMD were classified as: (i) iAMD without incomplete retinal pigment epithelium or outer retinal atrophy (iRORA) or subretinal drusenoid deposits (SDD); (ii) iAMD with SDD with no iRORA; (iii) iAMD with iRORA with no SDD and (iv) iAMD with iRORA and SDD. Factors associated with the incidence of late AMD were analysed using an interval-censored Weibull parametric proportional hazards model. Results: 983 eyes from 805 participants were analysed. Model-based cumulative incidence at nominal 2 years was 13.1% (95% CI 10.8–15.6%) for late AMD, 7.6% (95% CI 5.9–9.3%) for nAMD as the cause and 5.5% (95% CI 4.1–7.3%) for cRORA as the cause. Participants aged 75–84 (adjusted HR [aHR] 1.66, 95% CI 1.13–2.46; P = 0.01), 85 years+ (aHR 2.48, 95% CI 1.49–4.15; P = 0.001), presence of iRORA (aHR 1.50, 95% CI 1.05–2.16; P = 0.03), fellow-eye nAMD (aHR 3.23, 95% CI 2.04–5.12; P < 0.001) and BRVA 70–79 (vs 80 or better ETDRS letters: aHR 1.65, 95% CI 1.09–2.49; P = 0.02) had increased hazard of late AMD. Eyes that transitioned to neovascular AMD (nAMD) by 2 years (within tolerance window) displayed the greatest loss in BRVA compared to other phenotypes (–6.01 letters, SD 11.35). Conclusions: Approximately 13% of eyes with iAMD progressed to late AMD within 2 years. Eyes that transitioned to nAMD experienced the greatest loss in BRVA.| File | Dimensione | Formato | |
|---|---|---|---|
|
s41433-026-04759-9.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Licenza:
Nessuna licenza
Dimensione
816.88 kB
Formato
Adobe PDF
|
816.88 kB | Adobe PDF | [it] Default value: Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I metadati presenti in AIR sono rilasciati con licenza CCO mentre i file delle pubblicazioni sono rilasciati con licenza CC BY-SA, salvo diversa indicazione. In caso di violazione di copyright, contattare l'assistenza di AIR




